Clinical Trial: Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: PHASE III TRIAL ASSESSING THE INTEREST OF A MAINTENANCE CHEMOTHERAPY COMBINING DOCETAXEL (TAXOTERE) 5-FU AFTER INDUCTION TREATMENT BY AINTENSIVE CHEMOTHERAPY FOR INFLAMMATORY BRE
Brief Summary: To evaluate the benefit of adding docetaxel-5 fluorouracile (D-5FU) regimen after pre-operative epirubicin-cyclophosphamide (EC) and loco-regional treatment in inflammatory breast cancer (IBC).
Detailed Summary:
Sponsor: UNICANCER
Current Primary Outcome: disease-free survival rate [ Time Frame: 3 years ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: UNICANCER
Dates:
Date Received: December 14, 2014
Date Started: October 2000
Date Completion:
Last Updated: May 3, 2017
Last Verified: May 2017